eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | intestinal disease |
| Comorbidity | C0009402|colorectal cancer |
| Sentences | 43 |
| PubMedID- 24652326 | The available data point toward new therapeutic perspectives for pathological features such as functional gastrointestinal disorders associated with constipation, colorectal cancer, cystic fibrosis, asthma, hypertension, gastrointestinal barrier function damage associated with enteropathy, enteric infection, malnutrition, satiety, food preferences, obesity, metabolic syndrome, and effects on behavior and brain disorders such as attention deficit, hyperactivity disorder, and schizophrenia. |
| PubMedID- 23619008 | The risk of colorectal cancer in patients with inflammatory bowel diseases in finland: a follow-up of 20 years. |
| PubMedID- 21085072 | Surveillance for colorectal cancer in patients with inflammatory bowel disease. |
| PubMedID- 24280874 | Background: colitis-associated colorectal cancer affects individuals with inflammatory bowel disease (ibd) more often and earlier than cancer in the general population. |
| PubMedID- 20334955 | Conclusions: whereas htert immunostaining provides equivocal results, the observation that patients at high risk for colorectal cancer because of long-standing inflammatory bowel disease overexpress htert mrna in non-affected colorectal mucosa suggests its potential usefulness as a biomarker of the risk of malignant transformation. |
| PubMedID- 22522090 | Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. |
| PubMedID- 24407106 | Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases. |
| PubMedID- 25840920 | Molecular alterations of colorectal cancer with inflammatory bowel disease. |
| PubMedID- 22583410 | The risk of developing colorectal cancer increases in patients with inflammatory bowel disease (ibd) and a growing body of evidence shows the critical role of interleukin (il-6) in this process. |
| PubMedID- 23664897 | Epidemiological studies demonstrate an increased risk of colorectal cancer in patients with inflammatory bowel disease (ibd). |
| PubMedID- 24586180 | Chronic activation of immune responses results in health problems including gastrointestinal infections, metabolic imbalances and inflammatory bowel diseases that may lead to colorectal cancer. |
| PubMedID- 25531497 | colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk. |
| PubMedID- 21789787 | Interestingly, a recent study revealed that ntn1 expression is selectively up-regulated in colorectal cancers associated with bowel diseases. |
| PubMedID- 22122774 | Various chemopreventive agents have been clearly shown to reduce the risk of colorectal adenoma and cancer in the general population and the problems associated with colonoscopic surveillance have led to increasing interest in utilising chemopreventive strategies to reduce the risk of colorectal cancer in patients with inflammatory bowel disease as well. |
| PubMedID- 23407916 | Management of colorectal cancer in patients with inflammatory bowel disease. |
| PubMedID- 22919240 | colorectal cancer in patients with inflammatory bowel disease: can we predict risk. |
| PubMedID- 25849652 | [22] mir-21 was increased in inflammatory bowel disease (ibd) with or without colorectal cancer. |
| PubMedID- 25557336 | Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease. |
| PubMedID- 25230162 | colorectal cancer surveillance in patients with inflammatory bowel disease and primary sclerosing cholangitis: an economic evaluation. |
| PubMedID- 25041864 | A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease. |
| PubMedID- 24621115 | The best surveillance practices for colorectal cancer screening in patients with inflammatory bowel disease remains unclear. |
| PubMedID- 21386829 | A classic paradigm is the enhanced risk of colorectal cancer (crc) in patients with inflammatory bowel disease (ibd). |
| PubMedID- 23169309 | Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development. |
| PubMedID- 25337558 | Various chemopreventive agents have been clearly shown to reduce the risk of colorectal adenoma and cancer in the general population and the problems associated with colonoscopic surveillance have led to increasing interest in utilising chemopreventive strategies to reduce the risk of colorectal cancer in patients with inflammatory bowel disease as well.30 because colitis-associated cancers arose in the setting of chronic inflammation, during which “inflammation-dysplasia-carcinoma sequence” prevails and anti-inflammatory agents can prevent carcinogenesis, we have published data regarding chemoprevention of colitic cancer using infliximab31 and 8-ohdg.32 apart from colitic cancer, colorectal carcinogenesis is also based on a multi-step process characterized by molecular and cellular alterations that result in an identifiable precursor lesion, ie, the adenomatous polyp.33 the transition from normal mucosa to adenoma and its subsequent progression to carcinoma are protracted events that offer opportunities for preventive interventions. |
| PubMedID- 25113042 | Chromoendoscopy for colorectal cancer surveillance in patients with inflammatory bowel disease. |
| PubMedID- 25083052 | Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature. |
| PubMedID- 25157526 | The risk for developing dysplasia and colorectal cancer in patients with longstanding inflammatory bowel disease (ibd) involving the colon is well documented. |
| PubMedID- 24463282 | The risk of developing colorectal cancer is increased in patients with inflammatory bowel disease. |
| PubMedID- 19863607 | Aim: colorectal cancer is associated with inflammatory bowel disease. |
| PubMedID- 24788218 | Background: active colitis impairs neoplasia detection during colonoscopic surveillance for colorectal cancer in patients with inflammatory bowel disease. |
| PubMedID- 23086115 | Background: differentiating surveillance from non-surveillance colonoscopy for colorectal cancer in patients with inflammatory bowel disease (ibd) using electronic medical records (emr) is important for practice improvement and research purposes, but diagnosis code algorithms are lacking. |
| PubMedID- 20670073 | In the discussion, characteristics and major risk factors for colorectal cancer in patients with inflammatory bowel disease will be largely reviewed, and current studies will be analyzed in connection with the appearance of neoplasms in patients being treated with biologics. |
| PubMedID- 25596747 | For instance, ulcerative colitis (uc) is an inflammatory bowel disease that is associated with colorectal cancer (crc) [2]. |
| PubMedID- 22164923 | This position paper of the section of gastrointestinal oncology of the israeli gastroenterological association recommends specific guidelines for colorectal cancer surveillance in patients with inflammatory bowel disease. |
| PubMedID- 22228163 | Patients: colorectal cancer cases associated with inflammatory bowel disease diagnosed between 1990 and 2006 were selected in a nationwide pathology archive. |
| PubMedID- 23709348 | The risk of developing colorectal cancer (crc) increases in patients with inflammatory bowel disease. |
| PubMedID- 23605189 | Background: anatomical changes after intestinal resection and the effects of adjuvant treatment for colorectal cancer may lead to gastrointestinal disturbances. |
| PubMedID- 22523611 | colorectal cancer surveillance in patients with inflammatory bowel disease: what is new. |
| PubMedID- 23264896 | An exaggerated inflammatory response has been reported to increase the risk of colorectal cancer in patients with inflammatory bowel disease (ibd), ulcerative colitis (uc) or crohn’s disease. |
| PubMedID- 24076060 | Background & aims: although restorative proctocolectomy with ileal pouch-anal anastomosis (ipaa) substantially reduces the risk of colorectal cancer in patients with inflammatory bowel disease (ibd), subsequent pouch neoplasia can develop. |
| PubMedID- 25531498 | This review summarizes the advances and current standards of colorectal cancer prevention in patients with inflammatory bowel disease, fap and lynch syndrome. |
| PubMedID- 22398065 | Background: the increased risk of colorectal cancer (crc) in patients with inflammatory bowel disease (ibd) is well established. |
| PubMedID- 22369306 | Chronic inflammation plays a pivotal role in the development of colorectal cancer (crc) in patients with inflammatory bowel disease (ibd). |
Page: 1